ArticlePloS one2026
Alzheimer's disease prediction via an explainable CNN using genetic algorithm and SHAP values.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Steatosis liver index: A validated machine learning model using clinical data distinguishes steatotic liver disease phenotypes.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026Article
- Serum 1H NMR-Based Untargeted Metabolomics for Noninvasive Early Detection of Breast Cancer.Journal of proteome research · 2026Article
- Tertiary Lymphoid Structures as Predictors of Recurrence in Colorectal Cancer: Development and Validation of a Machine Learning-Based Scoring Model.Cancer medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Convolutional neural networks (CNNs) are widely recognized for their high precision in image classification. Nevertheless, the lack of transparency in these black-box models raises concerns in sensitive domains such as healthcare, where understanding the knowledge acquired to derive outcomes can be challenging. To address this concern, several strategies within the field of explainable AI (XAI) have been developed to enhance model interpretability. This study introduces a novel XAI technique, GASHAP, which integrates a genetic algorithm (GA) with SHapley Additive exPlanations (SHAP) to improve the explainability of our 3D convolutional neural network (3D-CNN) model. The model is designed to classify magnetic resonance imaging (MRI) brain scans of individuals with Alzheimer's disease and cognitively normal controls. Deep SHAP, a widely used XAI technique, facilitates the understanding of the influence exerted by various voxels on the final classification outcome (Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In: Advances in Neural Information Processing Systems, 2017. 4765-74. https://doi.org/10.5555/3295222.3295230). However, voxel-level representation alone lacks interpretive clarity. Therefore, the objective of this study is to provide findings at the level of anatomically defined brain regions. Critical regions are identified by leveraging their SHAP values, followed by the application of a genetic algorithm to generate a definitive mask highlighting the most significant regions for Alzheimer's disease diagnosis (Shahamat H, Saniee Abadeh M. Brain MRI analysis using a deep learning based evolutionary approach. Neural Netw. 2020;126:218-34. https://doi.org/10.1016/j.neunet.2020.03.017 PMID: 32259762). The research commenced by implementing a 3D-CNN for MRI image classification. Subsequently, the GASHAP technique was applied to enhance model transparency. The final result is a brain mask that delineates the pertinent regions crucial for Alzheimer's disease diagnosis. Finally, a comparative analysis is conducted between our findings and those of previous studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.